Allarity Therapeutics (ALLR) Other Non-Current Liabilities (2020 - 2024)
Allarity Therapeutics' (ALLR) quarterly Other Non-Current Liabilities came in at $1000.0 in Q4 2024, down 93.75% on a QoQ basis from $16000.0 in Q2 2024.
Allarity Therapeutics (ALLR) Other Non-Current Liabilities (2020 - 2024) Analysis & Trends
Allarity Therapeutics (ALLR) has 5 years of Other Non-Current Liabilities data on file, last reported at $1000.0 in Q4 2024.
- Quarterly Other Non-Current Liabilities changed N/A year-over-year to $1000.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $1000.0 (changed N/A YoY) and the FY2024 annual result came in at $1000.0, changed N/A from the prior year.
- Other Non-Current Liabilities slipped to $1000.0 in Q4 2024, from $16000.0 in the prior quarter.
- In the past five years, Other Non-Current Liabilities ranged from a high of $13.4 million in Q3 2022 to a low of $1000.0 in Q4 2024.
- A 5-year average of $1.9 million and a median of $354500.0 in 2022 frame the typical range for Other Non-Current Liabilities.
- Annual changes were most pronounced in 2022 — Other Non-Current Liabilities jumped 6066.06% — and 2024, when it plunged 98.6%.
- Tracing ALLR's Other Non-Current Liabilities over 5 years: stood at $1.5 million in 2020, then sank by 94.44% to $82000.0 in 2021, then surged by 387.8% to $400000.0 in 2022, then surged by 900.0% to $4.0 million in 2023, then slumped by 99.98% to $1000.0 in 2024.
- The last three Other Non-Current Liabilities figures came in at $1000.0 (Q4 2024), $16000.0 (Q2 2024), and $4.0 million (Q3 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Allarity Therapeutics | 22.75 Mn | 22.75 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 1,000.00 |
| Jun 30, 2024 | 16,000.00 |
| Sep 30, 2023 | 4.00 Mn |
| Jun 30, 2023 | 1.14 Mn |
| Mar 31, 2023 | 309,000.00 |
| Dec 31, 2022 | 400,000.00 |
| Sep 30, 2022 | 13.44 Mn |
| Jun 30, 2022 | 2.12 Mn |
| Mar 31, 2022 | 134,000.00 |
| Dec 31, 2021 | 82,000.00 |
| Sep 30, 2021 | 218,000.00 |
| Dec 31, 2020 | 1.48 Mn |